Federal contract award
75F40123F19006
FDA BUDGET EXECUTION AND CONTROL SUPPORT
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 541611 — Administrative Management and General Management Consulting Services |
| PSC | R699 — Other Administrative Support Services |
| Parent award / vehicle | 75F40121A00003 |
| Set-aside | Not reported |
| Pricing type | LABOR HOURS |
| Obligations | $20.5M |
| Current contract value | $21.4M |
| Potential contract value / ceiling | $21.9M |
| Start date | Dec 8, 2022 |
| Current end date | Sep 28, 2027 |
| Potential end date | Sep 28, 2027 |
| Latest award activity | Jul 22, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 17 of 17 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jul 22, 2026 | P00016 | $3.4M | EO 14398 - FDA BUDGET EXECUTION AND CONTROL SUPPORT, BETI PROCESS IMPROVEMENT, AND TRAVEL OPERATIONS |
| Apr 15, 2026 | P00015 | $1.5M | BETI PROCESS IMPROVEMENT AND TRAVEL OPERATIONS |
| Jan 26, 2026 | P00014 | $1.7M | BETI PROCESS IMPROVEMENT AND TRAVEL OPERATIONS |
| Jan 5, 2026 | P00013 | $0 | BETI PROCESS IMPROVEMENT AND TRAVEL OPERATIONS |
| Dec 2, 2025 | P00012 | $0 | BETI PROCESS IMPROVEMENT AND TRAVEL OPERATIONS |
| Nov 19, 2025 | P00011 | $1.1M | BETI PROCESS IMPROVEMENT AND TRAVEL OPERATIONS |
| Sep 30, 2025 | P00010 | $5.8M | BETI PROCESS IMPROVEMENT AND TRAVEL OPERATIONS |
| Sep 5, 2025 | P00009 | $-1.1M | DE-OBLIGATE FUNDS |
| Apr 29, 2025 | P00008 | $-370.7K | EOI::RADICAL TRANSPARENCY ABOUT WASTEFUL SPENDING (FEBRUARY 18, 2025) EOI::BILATERAL MODIFICATION PARTIAL TERMINATION |
| Mar 26, 2025 | P00007 | $0 | FDA BUDGET EXECUTION AND CONTROL SUPPORT |
| Nov 27, 2024 | P00006 | $2.9M | THE PURPOSE OF MODIFICATION IS TO 1) MODIFY OPTION YEAR 2; AND 2) EXERCISE THE MODIFIED OPTION YEAR 2. |
| Jun 27, 2024 | P00005 | $259.5K | THE PURPOSE OF THIS MODIFICATION IS TO ADD SUBSECTION 2.2.2.3 TRAINING PLAN MODULE 1: WHICH APPLIES TO OPTION YEAR 1. |
| Feb 23, 2024 | P00004 | $949.2K | FDA BUDGET EXECUTION AND CONTROL SUPPORT |
| Dec 4, 2023 | P00003 | $1.6M | FDA BUDGET EXECUTION AND CONTROL SUPPORT |
| Apr 28, 2023 | P00001 | $84.7K | FDA BUDGET EXECUTION AND CONTROL SUPPORT |
| Apr 28, 2023 | P00002 | $962.1K | FDA BUDGET EXECUTION AND CONTROL SUPPORT |
| Dec 8, 2022 | 0 | $1.8M | FDA BUDGET EXECUTION AND CONTROL SUPPORT |
Estimated positioning window
Nov 1, 2026 – Mar 28, 2027
85/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 85/100. Available recorded signals: 80 points.
- Contract end 2027-09-28 (331 days from calculation)
- +35 points
- 39 historical awards in this buyer and category group
- +15 points
- 17 recorded award transactions
- +10 points
- Latest award action: 2026-07-22
- +5 points
- Parent award identifier recorded
- +5 points
- Solicitation identifier recorded
- +10 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-11-01 10:17:53.997580+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Nov 1, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.